title: Differential regulation of CC chemokine receptors by 9-cis retinoic acid in the human mast cell line, HMC-1.
abstract: Mast cells are well known as effector cells in a variety of inflammatory diseases, including asthma as well as other allergic disorders. The precise role of 9-cis retinoic acid (9CRA) in mast cells is not understood despite the accepted fact that 9CRA regulates inflammatory responses and neutrophil differentiation. In this study, we investigated the effects of 9CRA on the expression of CC chemokine receptors in the human mast cell line, HMC-1. 9CRA selectively inhibits the CCR2 mRNA level and increases the CCR3 mRNA level in both a time and dose dependent manner. Other CC chemokine receptors, including CCR1, CCR4 and CCR5 are not altered by treatment with 9CRA. Both TNF-alpha and LPS, known pro-inflammatory molecules, have no effect on mRNA levels of CC chemokine receptors. For surface expression, 9CRA decreased the CCR2 level but had no effect on the CCR3 level. 9CRA inhibited the chemotactic activity in response to the CCR2-dependent chemokine, MCP-1/CCL2 but not in response to CCR3-specific chemokine, eotaxin/CCL11. 9CRA decreased spontaneous homotype clustering. Therefore, our results demonstrate that 9CRA differentially decreases both CCR2 expression and chemotactic ability of HMC-1 cells, and may regulate the inflammatory effects of mast cells.
authors.affiliation: School of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Republic of Korea.
authors.forename: Jesang
authors.initials: J
authors.lastname: Ko
authors.forename: Chi-Young
authors.initials: CY
authors.lastname: Yun
authors.forename: Ji-Sook
authors.initials: JS
authors.lastname: Lee
authors.forename: Dong-Hee
authors.initials: DH
authors.lastname: Kim
authors.forename: Ji Eun
authors.initials: JE
authors.lastname: Yuk
authors.forename: In Sik
authors.initials: IS
authors.lastname: Kim
mesh_terms: D000077556:Alitretinoin; D002449:Cell Aggregation / Q000187:drug effects; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D002633:Chemotaxis / Q000187:drug effects; D005434:Flow Cytometry; D006801:Humans; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism*; D054389:Receptors, CCR1; D054390:Receptors, CCR2; D019713:Receptors, CCR5 / Q000378:metabolism; D019707:Receptors, Chemokine / Q000096:biosynthesis / Q000378:metabolism*; D014212:Tretinoin / Q000494:pharmacology*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: C515300:CCR1 protein, human; C515334:CCR2 protein, human; D054389:Receptors, CCR1; D054390:Receptors, CCR2; D019713:Receptors, CCR5; D019707:Receptors, Chemokine; D000077556:Alitretinoin; D014212:Tretinoin; D048051:p38 Mitogen-Activated Protein Kinases